Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07318519 · ClinicalTrials.gov registry record · NA

Cognitive Behavioral Theory-assisted Virtual Reality for Chronic CANcer Pain (VR-CAN)

A NA study of Cancer and Cancer Pain, sponsored by Medstar Health Research Institute.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT07318519 is a NA study of Cancer and Cancer Pain that is actively recruiting participants, run by Medstar Health Research Institute. The registered enrollment target is 40 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07318519, a NA study of Cancer and Cancer Pain, is actively recruiting participants, sponsored by Medstar Health Research Institute.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

While chronic cancer pain affecting as many as 75% of patients is typically addressed using pharmacologic interventions, experts and patients alike support maximizing any relevant non-pharmacologic interventions as well, such as cognitive behavioral therapy. Virtual reality, a novel technology that can temporarily immerse users in a calm, pleasant environment, has been increasingly shown to facilitate improvement in different acute and chronic pain syndromes by providing distraction from pain and lowering pain sensation. To address the significant needs of patients living with chronic cancer pain, we aim to develop and pilot test a prototype device that will leverage cognitive behavioral therapy principles to deliver a novel virtual reality pain therapy. The investigators will do this through the following steps: Step 1. Develop and refine a CBT-assisted VR prototype for patients with chronic cancer pain (VR-CAN). Step 2. Conduct a randomized controlled trial to examine the feasibility, acceptability, usability, safety, and initial clinical impact of the developed VR-CAN prototype compared to a tablet-based two-dimensional video control group. Step 3. Collect and evaluate qualitative post-intervention data on VR-CAN participants' preferences, thoughts, and feelings about the VR-CAN technology and protocol to optimize for a future, larger, fully powered randomized controlled trial.

Interventions

  • DEVICE VR-CAN prototype chronic cancer pain therapy -- virtual reality program delivering CBT for chronic cancer pain management
  • DEVICE Active Control -- two-dimensional tablet-delivered intervention

Study Locations (2)

District of Columbia

  • MedStar Health Research Institute - Washington D.C.

North Carolina

  • Duke University School of Medicine - Durham

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-07-01
Est. Completion 2027-05-31
Phase NA

Sponsor

Medstar Health Research Institute

115 total trials

What the Registry Record Tells You About NCT07318519

The ClinicalTrials.gov registry entry for NCT07318519 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which VR-CAN prototype chronic cancer pain therapy -- virtual reality program delivering CBT for chronic cancer pain management is the first listed.

NCT07318519 reports 2 study locations spanning 2 distinct geographic areas - top geographies include District of Columbia, North Carolina.

Frequently Asked Questions

What is clinical trial NCT07318519 about?

NCT07318519 is a clinical study titled "Cognitive Behavioral Theory-assisted Virtual Reality for Chronic CANcer Pain (VR-CAN)". While chronic cancer pain affecting as many as 75% of patients is typically addressed using pharmacologic interventions, experts and patients alike support maximizing any relevant non-pharmacologic interventions as well, such as cognitive behavioral therapy. Virtual reality, a novel technology that ...

What is the current status of trial NCT07318519?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-07-01. Estimated completion is 2027-05-31.

What conditions does trial NCT07318519 study?

This clinical trial studies the following conditions: Cancer, Cancer Pain, Chronic Cancer Pain.

What interventions are being tested in trial NCT07318519?

The interventions under investigation include: VR-CAN prototype chronic cancer pain therapy -- virtual reality program delivering CBT for chronic cancer pain management (DEVICE), Active Control -- two-dimensional tablet-delivered intervention (DEVICE).

Who is sponsoring clinical trial NCT07318519?

This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07318519 being conducted?

This trial has 2 study locations across District of Columbia, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.